https://www.avient.com/sites/default/files/2023-11/Capture Oxygen Scavenger Product Bulletin.pdf
MARKETS AND APPLICATIONS
ColorMatrix Capture Oxygen Scavenger
is formulated to protect oxygen-sensitive
contents such as:
• Fruit and vegetable juice
• Nutritional and vitamin-fortified
beverages
• Ready-to-drink tea and coffee
• Milk and dairy beverages
• Wine
Capture has FDA food contact approval.
https://www.avient.com/sites/default/files/2021-04/colormatrix-optica-specialty-toners-for-pc-product-bulletin.pdf
MARKETS AND APPLICATIONS
ColorMatrix Optica is formulated for
PC resins used in the production of:
• Automotive interiors
• Appliance housings
• Consumer goods
• Food packaging
• Finished materials such as
PC sheet
• Electrical & Electronics
REGULATORY
• No heavy metals or restricted
ingredients
• In-house chemical testing and
verification system compliant with
ISO ISO/IEC 17025:2005
• Dedicated product stewardship
team globally and locally
https://www.avient.com/sites/default/files/2020-08/colormatrix-select-product-bulletin-1.pdf
Target samples/
specifications
Target samples/
specifications
Matches
Approvals
Trials
Approvals
Approvals
ApprovalsApprovals Trials
Designer BrandManufacturer
Target samples/
specifications
Target samples/
specifications
Matches
Approvals
Trials
Approvals
Approvals
ApprovalsApprovals Trials
Designer BrandManufacturer
MARKETS AND APPLICATIONS
Select is a system ideally suited for applications where
choice of color is vital but also uncertain.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Antistatic Application Bulletin_0.pdf
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2020-09/hiviz-recoil-pad-case-study.pdf
Taking a customer-first approach, HIVIZ identified
a need in the high-end market to drive recoil-damping
technology forward.
https://www.avient.com/sites/default/files/2020-08/oncolor-colorants-color-shades-of-nature-product-bulletin-1.pdf
Available in masterbatch solutions, these beautiful
effects are formulated with:
• organic waste materials, such as
almond shells
• glitter flakes
• synthetic fibers
• special effects, such as speckles
and pearlescents
KEY CHARACTERISTICS
• Available in standard or custom finishes
• Cost effective replacement for marble, granite,
and other expensive and heavy materials across
many applications
• No additional production investment required
MARKETS AND APPLICATIONS
Shades of Nature colorants can add depth
and dimension to:
• Packaging – including premium cosmetics
or luxury caps and closures
• Transportation – interior or exterior automotive
trim and components
• Consumer goods – toys, outdoor goods,
furniture
• Small and large household appliances
PRODUCT BULLETIN
NAME COLOR TONE EFFECTS EU FDA TOYS T STABILITY
Fossil Beige Fibers/Speckles YES NO YES 280°C
Lavender Purple Blue Fibers YES NO YES 280°C
Rosewood Light Pink Fibers NO NO NO 280°C
Emerald Creek Green Special Effects YES YES YES 280°C
Mother of Pearl White Pearl Special Effects YES YES YES 280°C
Invigorate Yellow Green Natural Waste NO NO YES < 210°C
Interstellar Brown Special Effects YES YES YES 280°C
Unrefined Grey Glitter NO NO NO 230°C
Reflection Blue Glitter NO NO NO 230°C
Coral Sand Orange Fibers NO NO NO 280°C
REGULATORY INFORMATION
IMPORTANT NOTE
The above technical and regulatory information is based on the formulation of the current 10 colors in the palette.
https://www.avient.com/company/sustainability/sustainability-report/reporting/gri
Avient products are not banned in any market.
Markets served
GRI 417: Marketing and Labeling
https://www.avient.com/sites/default/files/2022-04/Avient Q1 2022 Earnings Release.pdf
The company noted sales growth in nearly all end markets, as it continues to more than offset
inflation to deliver record results.
Factors that could cause
actual results to differ materially from those implied by these forward-looking statements include,
but are not limited to: the ability and time required to consummate the acquisition of Dyneema;
our ability to achieve the strategic and other objectives relating to the proposed acquisition of
Dyneema; disruptions, uncertainty or volatility in the credit markets that could adversely impact
the availability of credit already arranged and the availability and cost of credit in the future; the
effect on foreign operations of currency fluctuations, tariffs and other political, economic and
regulatory risks; the current and potential future impact of the COVID-19 pandemic on our
business, results of operations, financial position or cash flows; changes in polymer consumption
growth rates and laws and regulations regarding plastics in jurisdictions where we conduct
business; fluctuations in raw material prices, quality and supply, and in energy prices and supply;
production outages or material costs associated with scheduled or unscheduled maintenance
programs; unanticipated developments that could occur with respect to contingencies such as
litigation and environmental matters; an inability to raise or sustain prices for products or services;
information systems failures and cyberattacks; and other factors affecting our business beyond
our control, including without limitation, changes in the general economy, changes in interest
rates and changes in the rate of inflation.
Three Months Ended
March 31, 2022
Three Months Ended
March 31, 2021
Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS
Net income attributable to Avient shareholders $ 84.2 $ 0.91 $ 79.3 $ 0.86
Special items, after tax (Attachment 3) 7.2 0.08 2.6 0.03
Adjusted net income / EPS - excluding special items $ 91.4 $ 0.99 $ 81.9 $ 0.89
6
Attachment 2
Avient Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
March 31,
2022 2021
Sales $ 1,293.8 $ 1,162.3
Cost of sales 1,000.1 859.9
Gross margin 293.7 302.4
Selling and administrative expense 165.1 182.0
Operating income 128.6 120.4
Interest expense, net (16.9) (19.3)
Other (expense) income, net (0.6) 1.5
Income before income taxes 111.1 102.6
Income taxes (26.6) (22.9)
Net income 84.5 79.7
Net income attributable to noncontrolling interests (0.3) (0.4)
Net income attributable to Avient shareholders $ 84.2 $ 79.3
Earnings per share attributable to Avient common shareholders - Basic $ 0.92 $ 0.87
Earnings per share attributable to Avient common shareholders - Diluted $ 0.91 $ 0.86
Cash dividends declared per share of common stock $ 0.2375 $ 0.2125
Weighted-average shares used to compute earnings per common share:
Basic 91.5 91.3
Diluted 92.3 92.2
7
Attachment 3
Avient Corporation
Summary of Special Items (Unaudited)
(In millions, except per share data)
Special items (1)
Three Months Ended
March 31,
2022 2021
Cost of sales:
Restructuring costs, including accelerated depreciation and amortization $ (4.4) $ (1.8)
Environmental remediation costs (2.0) (0.5)
Reimbursement of previously incurred environmental costs 0.6 4.5
Impact on cost of sales (5.8) 2.2
Selling and administrative expense:
Restructuring, legal and other 0.9 (1.3)
Acquisition related costs (2.9) (3.3)
Impact on selling and administrative expense (2.0) (4.6)
Impact on operating income (7.8) (2.4)
Other income, net 0.1 —
Impact on income before income taxes (7.7) (2.4)
Income tax benefit on above special items 2.0 0.9
Tax adjustments(2) (1.5) (1.1)
Impact of special items on net income attributable to Avient Shareholders $ (7.2) $ (2.6)
Diluted earnings per common share impact $ (0.08) $ (0.03)
Weighted average shares used to compute adjusted earnings per share:
Diluted 92.3 92.2
(1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt
extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel
reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-
market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation
costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the
divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results
of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the
performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting
reported results
https://www.avient.com/sites/default/files/2022-09/Avient Pro Forma Financial Information.pdf
In particular, these include statements relating to future actions;
prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of
contingencies such as legal proceedings and environmental liabilities; and financial results.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; including recessionary conditions
• The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows
• Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to raise or sustain prices for products or services;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
• The ability to obtain required regulatory approvals and otherwise consummate the proposed sales of the Distribution business; and
• Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting principles) and non-GAAP financial measures.